Aggressive treatment of b cell non hodgkin lymphoma a protocol of the french pediatric oncology society preliminary results on 60 patients. European Journal Of Cancer & Clinical Oncology: 1052, 1982
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group. Annals of Oncology 23(5): 1267-1273, 2012
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Annals of Oncology 19(3): 545-552, 2007
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 116(18): 3418-3425, 2010
Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol. Srpski Arhiv Za Celokupno Lekarstvo 126(9-10): 345-348, 1998
Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice. Annals of Hematology 94(9): 1553-1558, 2015
Prognostic value of positron emission tomography (PET) scan in patients with relapsed Hodgkin lymphoma or aggressive Non-Hodgkin lymphoma receiving salvage chemotherapy followed by reduced-intensity allogeneic stem cell transplantation. 2007
New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. Journal of Clinical Oncology 20(1): 221-230, 2002
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Annals of Oncology 14(6): 881-893, 2003
Hematopoietic stem cell transplantation as salvage treatment in patients with aggressive non-Hodgkin's lymphoma. Medicina Clinica 114(4): 128-131, 2000
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation. Cancer 116(21): 5001-5011, 2010
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Blood 113(17): 3896-3902, 2009
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Annals of Oncology 18(1): 149-157, 2006
Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients. Leukemia and Lymphoma 51(8): 1513-1522, 2010
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network. European Journal of Nuclear Medicine and Molecular Imaging 41(8): 1585-1592, 2015